Advanced search
Publication Cover
Future Oncology Volume 5, 2009 - Issue 8
Submit an article Journal homepage
1,015
Views
2
CrossRef citations to date
0
Altmetric
Review

Epithelial–Mesenchymal Transition in Development and Cancer

Douglas S Micalizzia Program in Molecular Biology, Medical Scientist Training Program, University of Colorado School of Medicine, AuroraCO80045, USAView further author information
&
Heide L Fordb Departments of Obstetrics and Gynecology and Biochemistry and Molecular Genetics, University of Colorado School of Medicine, AuroraCO80045, USA. [email protected]Correspondence[email protected]
View further author information
Pages 1129-1143 | Published online: 26 Oct 2009

Bibliography

  • Solnica-Krezel L : Conserved patterns of cell movements during vertebrate gastrulation.Curr. Biol.15(6), R213–R228 (2005).
  • Mercado-Pimentel ME , RunyanRB: Multiple transforming growth factor-β isoforms and receptors function during epithelial–mesenchymal cell transformation in the embryonic heart.Cells Tissues Organs185(1–3), 146–156 (2007).
  • Nawshad A , LaGambaD, HayED: Transforming growth factor β (TGFβ) signalling in palatal growth, apoptosis and epithelial mesenchymal transformation (EMT).Arch. Oral Biol.49(9), 675–689 (2004).
  • Tucker RP : Neural crest cells: a model for invasive behavior.Int. J. Biochem. Cell Biol.36(2), 173–177 (2004).
  • Shook D , KellerR: Mechanisms, mechanics and function of epithelial–mesenchymal transitions in early development.Mech. Dev.120(11), 1351–1383 (2003).
  • Kalluri R , NeilsonEG: Epithelial–mesenchymal transition and its implications for fibrosis.J. Clin. Invest.112(12), 1776–1784 (2003).
  • Thiery JP : Epithelial–mesenchymal transitions in tumor progression.Nat. Rev. Cancer2(6), 442–454 (2002).
  • Olmeda D , MontesA, Moreno-BuenoG, FloresJM, PortilloF, CanoA: Snai1 and Snai2 collaborate on tumor growth and metastasis properties of mouse skin carcinoma cell lines.Oncogene27(34), 4690–4701 (2008).
  • Yang J , ManiSA, DonaherJLet al.: Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis.Cell117(7), 927–939 (2004).
  • Micalizzi DS , ChristensenKL, JedlickaPet al.: The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial–mesenchymal transition and metastasis in mice through TGF-β signaling.J. Clin. Invest.119(9), 2678–2690 (2009).
  • Self M , LagutinOV, BowlingBet al.: Six2 is required for suppression of nephrogenesis and progenitor renewal in the developing kidney.EMBO J.25(21), 5214–5228 (2006).
  • Jakowlew SB : Transforming growth factor-β in cancer and metastasis.Cancer Metastasis Rev.25(3), 435–457 (2006).
  • Brabletz T , HlubekF, SpadernaSet al.: Invasion and metastasis in colorectal cancer: epithelial–mesenchymal transition, mesenchymal-epithelial transition, stem cells and β-catenin.Cells Tissues Organs179(1–2), 56–65 (2005).
  • Yang J , WeinbergRA: Epithelial–mesenchymal transition: at the crossroads of development and tumor metastasis.Dev. Cell14(6), 818–829 (2008).
  • Moustakas A , HeldinCH: Signaling networks guiding epithelial–mesenchymal transitions during embryogenesis and cancer progression.Cancer Sci.98(10), 1512–1520 (2007).
  • Muller HA : Of mice, frogs and flies: generation of membrane asymmetries in early development.Dev. Growth Differ.43(4), 327–342 (2001).
  • Hay ED : The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it.Dev. Dyn.233(3), 706–720 (2005).
  • Nakaya Y , SukowatiEW, WuY, ShengG: RhoA and microtubule dynamics control cell-basement membrane interaction in EMT during gastrulation.Nat. Cell Biol.10(7), 765–775 (2008).
  • Romano LA , RunyanRB: Slug is an essential target of TGFβ2 signaling in the developing chicken heart.Dev. Biol.223(1), 91–102 (2000).
  • Carver EA , JiangR, LanY, OramKF, GridleyT: The mouse snail gene encodes a key regulator of the epithelial–mesenchymal transition.Mol. Cell. Biol.21(23), 8184–8188 (2001).
  • Yu W , KamaraH, SvobodaKK: The role of twist during palate development.Dev. Dyn.237(10), 2716–2725 (2008).
  • Nawshad A , HayED: TGFβ3 signaling activates transcription of the LEF1 gene to induce epithelial mesenchymal transformation during mouse palate development.J. Cell Biol.163(6), 1291–1301 (2003).
  • Morkel M , HuelskenJ, WakamiyaMet al.: β-catenin regulates Cripto- and Wnt3-dependent gene expression programs in mouse axis and mesoderm formation.Development130(25), 6283–6294 (2003).
  • Baum B , SettlemanJ, QuinlanMP: Transitions between epithelial and mesenchymal states in development and disease.Semin. Cell Dev. Biol.19(3), 294–308 (2008).
  • Martinez-Alvarez C , BlancoMJ, PerezRet al.: Snail family members and cell survival in physiological and pathological cleft palates.Dev. Biol.265(1), 207–218 (2004).
  • Azhar M , Schultz JelJ, GruppIet al.: Transforming growth factor β in cardiovascular development and function.Cytokine Growth Factor Rev.14(5), 391–407 (2003).
  • Savagner P , KusewittDF, CarverEAet al.: Developmental transcription factor slug is required for effective re-epithelialization by adult keratinocytes.J. Cell Physiol.202(3), 858–866 (2005).
  • Guarino M , RubinoB, BallabioG: The role of epithelial–mesenchymal transition in cancer pathology.Pathology39(3), 305–318 (2007).
  • Gavert N , Ben-Ze’evA: Epithelial–mesenchymal transition and the invasive potential of tumors.Trends Mol. Med.14(5), 199–209 (2008).
  • Trimboli AJ , FukinoK, de BruinAet al.: Direct evidence for epithelial–mesenchymal transitions in breast cancer.Cancer Res.68(3), 937–945 (2008).
  • Massague J : TGFβ in cancer.Cell.134(2), 215–230 (2008).
  • Crawford SE , StellmachV, Murphy-UllrichJEet al.: Thrombospondin-1 is a major activator of TGF-β1 in vivo.Cell93(7), 1159–1170 (1998).
  • Massague J , SeoaneJ, WottonD: Smad transcription factors.Genes Dev.19(23), 2783–2810 (2005).
  • Blobe GC , SchiemannWP, LodishHF: Role of transforming growth factor β in human disease.N. Engl. J. Med.342(18), 1350–1358 (2000).
  • Ravitz MJ , WennerCE: Cyclin-dependent kinase regulation during G1 phase and cell cycle regulation by TGF-β.Adv. Cancer Res.71165–207 (1997).
  • Bartram U , MolinDG, WisseLJet al.: Double-outlet right ventricle and overriding tricuspid valve reflect disturbances of looping, myocardialization, endocardial cushion differentiation, and apoptosis in TGF-β(2)-knockout mice.Circulation103(22), 2745–2752 (2001).
  • Sridurongrit S , LarssonJ, SchwartzR, Ruiz-LozanoP, KaartinenV: Signaling via the TGF-β type I receptor Alk5 in heart development.Dev. Biol.322(1), 208–218 (2008).
  • Miettinen PJ , EbnerR, LopezAR, DerynckR: TGF-β induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors.J. Cell Biol.127(6 Pt 2), 2021–2036 (1994).
  • Oft M , HeiderKH, BeugH: TGFβ signaling is necessary for carcinoma cell invasiveness and metastasis.Curr. Biol.8(23), 1243–1252 (1998).
  • Zavadil J , BottingerEP: TGF-β and epithelial-to-mesenchymal transitions.Oncogene24(37), 5764–5774 (2005).
  • Ozdamar B , BoseR, Barrios-RodilesM, WangHR, ZhangY, WranaJL: Regulation of the polarity protein Par6 by TGFβ receptors controls epithelial cell plasticity.Science307(5715), 1603–1609 (2005).
  • Peinado H , QuintanillaM, CanoA: Transforming growth factor β-1 induces snail transcription factor in epithelial cell lines: mechanisms for epithelial mesenchymal transitions.J. Biol. Chem.278(23), 21113–21123 (2003).
  • Bhowmick NA , GhiassiM, BakinAet al.: Transforming growth factor-β1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism.Mol. Biol. Cell.12(1), 27–36 (2001).
  • Gregory PA , BertAG, PatersonELet al.: The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1.Nat. Cell Biol.10(5), 593–601 (2008).
  • Kong W , YangH, HeLet al.: MicroRNA-155 is regulated by the transforming growth factor β/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA.Mol. Cell. Biol.28(22), 6773–6784 (2008).
  • Stefani G , SlackFJ: Small noncoding RNAs in animal development.Nat. Rev. Mol. Cell Biol.9(3), 219–230 (2008).
  • Hannon GJ , BeachD: p15INK4B is a potential effector of TGF-β-induced cell cycle arrest.Nature371(6494), 257–261 (1994).
  • Reynisdottir I , PolyakK, IavaroneA, MassagueJ: Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β.Genes Dev.9(15), 1831–1845 (1995).
  • Cui W , FowlisDJ, BrysonSet al.: TGFβ1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice.Cell86(4), 531–542 (1996).
  • Chen CR , KangY, MassagueJ: Defective repression of c-myc in breast cancer cells: a loss at the core of the transforming growth factor β growth arrest program.Proc. Natl Acad. Sci. USA98(3), 992–999 (2001).
  • Baldwin RL , TranH, KarlanBY: Loss of c-myc repression coincides with ovarian cancer resistance to transforming growth factor β growth arrest independent of transforming growth factor β/Smad signaling.Cancer Res.63(6), 1413–1419 (2003).
  • Janda E , LehmannK, KillischIet al.: Ras and TGF[β] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways.J. Cell Biol.156(2), 299–313 (2002).
  • Rees JR , OnwuegbusiBA, SaveVE, AldersonD, FitzgeraldRC: In vivo and in vitro evidence for transforming growth factor-β1-mediated epithelial to mesenchymal transition in esophageal adenocarcinoma.Cancer Res.66(19), 9583–9590 (2006).
  • Vasko V , EspinosaAV, ScoutenWet al.: Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion.Proc. Natl Acad. Sci. USA104(8), 2803–2808 (2007).
  • Liu X : Inflammatory cytokines augments TGF-β1-induced epithelial–mesenchymal transition in A549 cells by up-regulating TβR-I.Cell Motil. Cytoskeleton65(12), 935–944 (2008).
  • Soufla G , SifakisS, BaritakiS, ZafiropoulosA, KoumantakisE, SpandidosDA: VEGF, FGF2, TGFB1 and TGFBR1 mRNA expression levels correlate with the malignant transformation of the uterine cervix.Cancer Lett.221(1), 105–118 (2005).
  • Kjellman C , OlofssonSP, HanssonOet al.: Expression of TGF-β isoforms, TGF-β receptors, and SMAD molecules at different stages of human glioma.Int. J. Cancer89(3), 251–258 (2000).
  • Takanami I , TanakaF, HashizumeT, KodairaS: Roles of the transforming growth factor β 1 and its type I and II receptors in the development of a pulmonary adenocarcinoma: results of an immunohistochemical study.J. Surg. Oncol.64(4), 262–267 (1997).
  • Ghellal A , LiC, HayesM, ByrneG, BundredN, KumarS: Prognostic significance of TGF β 1 and TGF β 3 in human breast carcinoma.Anticancer Res.20(6B), 4413–4418 (2000).
  • Mu L , KatsarosD, LuLet al.: TGF-β1 genotype and phenotype in breast cancer and their associations with IGFs and patient survival.Br. J. Cancer99(8), 1357–1363 (2008).
  • Langenskiold M , HolmdahlL, FalkP, AngeneteE, IvarssonML: Increased TGF-β 1 protein expression in patients with advanced colorectal cancer.J. Surg. Oncol.97(5), 409–415 (2008).
  • Ivanovic V , Todorovic-RakovicN, DemajoMet al.: Elevated plasma levels of transforming growth factor-β 1 (TGF-β 1) in patients with advanced breast cancer: association with disease progression.Eur. J. Cancer39(4), 454–461 (2003).
  • Muraoka RS , DumontN, RitterCAet al.: Blockade of TGF-β inhibits mammary tumor cell viability, migration, and metastases.J. Clin. Invest.109(12), 1551–1559 (2002).
  • Muraoka-Cook RS , ShinI, YiJYet al.: Activated type I TGFβ receptor kinase enhances the survival of mammary epithelial cells and accelerates tumor progression.Oncogene25(24), 3408–3423 (2006).
  • Kemler R , HierholzerA, KanzlerBet al.: Stabilization of β-catenin in the mouse zygote leads to premature epithelial–mesenchymal transition in the epiblast.Development131(23), 5817–5824 (2004).
  • Liebner S , CattelinoA, GalliniRet al.: β-catenin is required for endothelial-mesenchymal transformation during heart cushion development in the mouse.J. Cell Biol.166(3), 359–367 (2004).
  • Nelson WJ , NusseR: Convergence of Wnt, β-catenin, and cadherin pathways.Science303(5663), 1483–1487 (2004).
  • Conacci-Sorrell M , SimchaI, Ben-YedidiaT, BlechmanJ, SavagnerP, Ben-Ze’evA: Autoregulation of E-cadherin expression by cadherin–cadherin interactions: the roles of β-catenin signaling, Slug, and MAPK.J. Cell Biol.163(4), 847–857 (2003).
  • Gilles C , PoletteM, MestdagtMet al.: Transactivation of vimentin by β-catenin in human breast cancer cells.Cancer Res.63(10), 2658–2664 (2003).
  • Gradl D , KuhlM, WedlichD: The Wnt/Wg signal transducer β-catenin controls fibronectin expression.Mol. Cell. Biol.19(8), 5576–5587 (1999).
  • Huber MA , KrautN, BeugH: Molecular requirements for epithelial–mesenchymal transition during tumor progression.Curr. Opin. Cell Biol.17(5), 548–558 (2005).
  • Kim K , LuZ, HayED: Direct evidence for a role of β-catenin/LEF-1 signaling pathway in induction of EMT.Cell Biol. Int.26(5), 463–476 (2002).
  • Yook JI , LiXY, OtaIet al.: A Wnt-Axin2-GSK3β cascade regulates Snail1 activity in breast cancer cells.Nat. Cell Biol.8(12), 1398–1406 (2006).
  • Wong SC , LoES, LeeKC, ChanJK, HsiaoWL: Prognostic and diagnostic significance of β-catenin nuclear immunostaining in colorectal cancer.Clin. Cancer Res.10(4), 1401–1408 (2004).
  • Cano A , Perez-MorenoMA, RodrigoIet al.: The transcription factor snail controls epithelial–mesenchymal transitions by repressing E-cadherin expression.Nat. Cell Biol.2(2), 76–83 (2000).
  • Taneyhill LA , ColesEG, Bronner-FraserM: Snail2 directly represses cadherin6B during epithelial-to-mesenchymal transitions of the neural crest.Development134(8), 1481–1490 (2007).
  • Batlle E , SanchoE, FranciCet al.: The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumor cells.Nat. Cell Biol.2(2), 84–89 (2000).
  • Usami Y , SatakeS, NakayamaFet al.: Snail-associated epithelial–mesenchymal transition promotes oesophageal squamous cell carcinoma motility and progression.J. Pathol.215(3), 330–339 (2008).
  • Dhasarathy A , KajitaM, WadePA: The transcription factor snail mediates epithelial to mesenchymal transitions by repression of estrogen receptor-α.Mol. Endocrinol.21(12), 2907–2918 (2007).
  • Kurrey NK , KA, BapatSA: Snail and Slug are major determinants of ovarian cancer invasiveness at the transcription level.Gynecol. Oncol.97(1), 155–165 (2005).
  • Moreno-Bueno G , CubilloE, SarrioDet al.: Genetic profiling of epithelial cells expressing E-cadherin repressors reveals a distinct role for Snail, Slug, and E47 factors in epithelial–mesenchymal transition.Cancer Res.66(19), 9543–9556 (2006).
  • Savagner P , YamadaKM, ThieryJP: The zinc-finger protein slug causes desmosome dissociation, an initial and necessary step for growth factor-induced epithelial–mesenchymal transition.J. Cell Biol.137(6), 1403–1419 (1997).
  • Jorda M , OlmedaD, VinyalsAet al.: Upregulation of MMP-9 in MDCK epithelial cell line in response to expression of the Snail transcription factor.J. Cell Sci.118(Pt 15), 3371–3385 (2005).
  • de Boer TP , van VeenTA, BierhuizenMFet al.: Connexin43 repression following epithelium-to-mesenchyme transition in embryonal carcinoma cells requires Snail1 transcription factor.Differentiation75(3), 208–218 (2007).
  • Bolos V , PeinadoH, Perez-MorenoMA, FragaMF, EstellerM, CanoA: The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors.J. Cell Sci.116(Pt 3), 499–511 (2003).
  • Park SH , CheungLW, WongAS, LeungPC: Estrogen regulates Snail and Slug in the down-regulation of E-cadherin and induces metastatic potential of ovarian cancer cells through estrogen receptor α.Mol. Endocrinol.22(9), 2085–2098 (2008).
  • Fujita N , JayeDL, KajitaM, GeigermanC, MorenoCS, WadePA: MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer.Cell113(2), 207–219 (2003).
  • Blanco MJ , Moreno-BuenoG, SarrioDet al.: Correlation of Snail expression with histological grade and lymph node status in breast carcinomas.Oncogene21(20), 3241–3246 (2002).
  • Waldmann J , FeldmannG, SlaterEPet al.: Expression of the zinc-finger transcription factor Snail in adrenocortical carcinoma is associated with decreased survival.Br. J. Cancer99(11), 1900–1907 (2008).
  • Castro Alves C , RosivatzE, SchottCet al.: Slug is overexpressed in gastric carcinomas and may act synergistically with SIP1 and Snail in the down-regulation of E-cadherin.J. Pathol.211(5), 507–515 (2007).
  • Shioiri M , ShidaT, KodaKet al.: Slug expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients.Br. J. Cancer94(12), 1816–1822 (2006).
  • Olmeda D , JordaM, PeinadoH, FabraA, CanoA: Snail silencing effectively suppresses tumor growth and invasiveness.Oncogene26(13), 1862–1874 (2007).
  • Moody SE , PerezD, PanTCet al.: The transcriptional repressor Snail promotes mammary tumor recurrence.Cancer Cell8(3), 197–209 (2005).
  • Vesuna F , van DiestP, ChenJH, RamanV: Twist is a transcriptional repressor of E-cadherin gene expression in breast cancer.Biochem. Biophys. Res. Commun.367(2), 235–241 (2008).
  • Cheng GZ , ChanJ, WangQ, ZhangW, SunCD, WangLH: Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel.Cancer Res.67(5), 1979–1987 (2007).
  • Lee YH , AlbigAR, MaryannR, SchiemannBJ, SchiemannWP: Fibulin-5 initiates epithelial–mesenchymal transition (EMT) and enhances EMT induced by TGF-{β} in mammary epithelial cells via a MMP-dependent mechanism.Carcinogenesis29(12), 2243–2251 (2008).
  • Yang MH , WuKJ: TWIST activation by hypoxia inducible factor-1 (HIF-1 ): implications in metastasis and development.Cell Cycle7(14), 2090–2096 (2008).
  • Yang MH , WuMZ, ChiouSHet al.: Direct regulation of TWIST by HIF-1 α promotes metastasis.Nat. Cell Biol.10(3), 295–305 (2008).
  • Lo HW , HsuSC, XiaWet al.: Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial–mesenchymal transition in cancer cells via up-regulation of TWIST gene expression.Cancer Res.67(19), 9066–9076 (2007).
  • Niu RF , ZhangL, XiGMet al.: Upregulation of Twist induces angiogenesis and correlates with metastasis in hepatocellular carcinoma.J. Exp. Clin. Cancer Res.26(3), 385–394 (2007).
  • Yuen HF , KwokWK, ChanKKet al.: TWIST modulates prostate cancer cell-mediated bone cell activity and is upregulated by osteogenic induction.Carcinogenesis29(8), 1509–1518 (2008).
  • Fondrevelle ME , KantelipB, ReiterREet al.: The expression of Twist has an impact on survival in human bladder cancer and is influenced by the smoking status.Urol. Oncol.27(3), 268–276 (2008).
  • Kyo S , SakaguchiJ, OhnoSet al.: High Twist expression is involved in infiltrative endometrial cancer and affects patient survival.Hum. Pathol.37(4), 431–438 (2006).
  • Li X , OghiKA, ZhangJet al.: Eya protein phosphatase activity regulates Six1-Dach-Eya transcriptional effects in mammalian organogenesis.Nature426(6964), 247–254 (2003).
  • Oliver G , WehrR, JenkinsNAet al.: Homeobox genes and connective tissue patterning.Development121(3), 693–705 (1995).
  • Laclef C , HamardG, DemignonJ, SouilE, HoubronC, MaireP: Altered myogenesis in Six1-deficient mice.Development130(10), 2239–2252 (2003).
  • Xu PX , ZhengW, HuangL, MaireP, LaclefC, SilviusD: Six1 is required for the early organogenesis of mammalian kidney.Development130(14), 3085–3094 (2003).
  • Birchmeier C , BrohmannH: Genes that control the development of migrating muscle precursor cells.Curr. Opin. Cell Biol.12(6), 725–730 (2000).
  • Ozaki H , WatanabeY, TakahashiKet al.: Six4, a putative myogenin gene regulator, is not essential for mouse embryonal development.Mol. Cell. Biol.21(10), 3343–3350 (2001).
  • Grifone R , DemignonJ, HoubronCet al.: Six1 and Six4 homeoproteins are required for Pax3 and Mrf expression during myogenesis in the mouse embryo.Development132(9), 2235–2249 (2005).
  • McCoy EL , JedlickaP, AbbeyNet al.: Six1 expands the mouse mammary epithelial stem/progenitor cell pool and induces mammary tumors that undergo epithelial–mesenchymal transition.J. Clin. Invest.119(9) 2663–2677 (2009).
  • Ford HL , KabinguEN, BumpEA, MutterGL, PardeeAB: Abrogation of the G2 cell cycle checkpoint associated with overexpression of HSIX1: a possible mechanism of breast carcinogenesis.Proc. Natl Acad. Sci. USA95(21), 12608–12613 (1998).
  • Reichenberger KJ , ColettaRD, SchulteAP, Varella-GarciaM, FordHL: Gene amplification is a mechanism of Six1 overexpression in breast cancer.Cancer Res.65(7), 2668–2675 (2005).
  • Behbakht K , QamarL, AldridgeCSet al.: Six1 overexpression in ovarian carcinoma causes resistance to TRAIL-mediated apoptosis and is associated with poor survival.Cancer Res.67(7), 3036–3042 (2007).
  • Kloth JN , FleurenGJ, OostingJet al.: Substantial changes in gene expression of Wnt, MAPK and TNFα pathways induced by TGF-β1 in cervical cancer cell lines.Carcinogenesis26(9), 1493–1502 (2005).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.